Form 4: SI-BONE Director Thomas A. West Acquires Shares Through Restricted Stock Unit Settlement
SEC Form 4
Director Thomas A. West acquired 8,791 shares of SI-BONE, Inc. common stock on June 26, 2024, through the settlement of restricted stock units.
Summary
- On June 26, 2024, Thomas A. West, a director of SI-BONE, Inc., acquired 8,791 shares of common stock.
- The acquisition was a result of the settlement of restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of SI-BONE's common stock.
- The shares are vesting in 12 equal quarterly increments, starting on the Vesting Commencement Date, contingent upon continuous service on the Board of Directors.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests between management and shareholders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding the director's holdings in the company.
Key Dates
| Date | Description |
|---|---|
| 06/26/2024 | Date of transaction: Thomas A. West acquired 8,791 shares of SI-BONE common stock through RSU settlement. |
| 06/27/2024 | Date of signature: Form 4 signed by Michael A. Pisetsky, Attorney-in-Fact for Thomas A. West. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.